首页|参附注射液联合常规西药治疗慢性心力衰竭合并冠心病患者的效果

参附注射液联合常规西药治疗慢性心力衰竭合并冠心病患者的效果

扫码查看
目的:观察参附注射液联合常规西药治疗慢性心力衰竭合并冠心病患者的效果.方法:选取 2022 年 6 月至 2023 年 11 月该院收治的100例慢性心力衰竭合并冠心病患者进行前瞻性研究,按照随机数字表法分为研究组与对照组各50例.对照组采用常规西药(美托洛尔、贝那普利、曲美他嗪)治疗,研究组在对照组基础上联合参附注射液治疗,比较两组治疗总有效率、心功能指标[左心室射血分数(LVEF)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、室间隔厚度(IVST)]水平、血管内皮功能指标(一氧化氮、内皮素-1)水平、心肌损伤指标[血清肌酸激酶同工酶(CK-MB)、N末端B型利钠肽原(NT-proBNP)、血管紧张素Ⅱ(AngⅡ)]水平和不良反应发生率.结果:研究组治疗总有效率为 96.00%,明显高于对照组的 84.00%,差异有统计学意义(P<0.05);治疗后,研究组LVEF、血清一氧化氮水平高于对照组,IVST、LVESD、LVEDD和血清内皮素-1、AngⅡ、CK-MB、NT-proBNP水平低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:参附注射液联合常规西药治疗慢性心力衰竭合并冠心病患者可提高治疗总有效率,改善心功能指标和血管内皮功能指标水平,降低心肌损伤指标水平,效果优于单纯常规西药治疗.
Effects of Shenfu injection combined with conventional Western medicine in treatment of patients with chronic heart failure complicated with coronary heart disease
Objective:To observe effects of Shenfu injection combined with conventional Western medicine in treatment of patients with chronic heart failure complicated with coronary heart disease.Methods:A prospective study was conducted on 100 patients with chronic heart failure and coronary heart disease admitted to this hospital from June 2022 to November 2023.According to the random number table method,they were divided into study group and control group,50 cases in each group.The control group was treated with conventional Western medicine(Metoprolol,Benazepril,Trimetazidine),while the study group was treated with Shenfu injection on the basis of that of the control group.The total effective rate of treatment,the levels of cardiac function indexes[left ventricular ejection fraction(LVEF),left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD),interventricular septal thickness(IVST)],vascular endothelial function indexes(nitric oxide,endothelin-1)and myocardial injury indexes[serum creatine kinase isoenzyme(CK-MB),N-terminal B-type natriuretic peptide(NT-proBNP),angiotensin II(Ang II)],and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 96.00%,which was significantly higher than 84.00%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of LVEF and serum nitric oxide in the study group were higher than those in the control group,the levels of IVST,LVESD,LVEDD,serum endothelin-1,AngII,CK-MB and NT-proBNP were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Shenfu injection combined with conventional Western medicine in the treatment of the patients with chronic heart failure and coronary heart disease can improve the total effective rate of treatment,improve the levels of cardiac function indexes and vascular endothelial function indexes,and reduce the levels of myocardial injury indexes.Moreover,it is superior to simple conventional Western medicine treatment.

Shenfu injectionCoronary heart diseaseHeart failureCardiac functionVascular endothelial functionMyocardial injuryAdverse reaction

李志英、张景迪、孙丹

展开 >

南阳医学高等专科学校第一附属医院心血管内科三病区,河南 南阳 473000

参附注射液 冠心病 心力衰竭 心功能 血管内皮功能 心肌损伤 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(19)